BI

BVF Inc Portfolio holdings

AUM $2.8B
This Quarter Return
+20.82%
1 Year Return
+17.96%
3 Year Return
+404.14%
5 Year Return
+563.41%
10 Year Return
+5,885.83%
AUM
$2.42B
AUM Growth
+$2.42B
Cap. Flow
+$150M
Cap. Flow %
6.2%
Top 10 Hldgs %
42.31%
Holding
83
New
4
Increased
11
Reduced
18
Closed
3
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
CALT
51
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$11.3M 0.47%
750,000
CTMX icon
52
CytomX Therapeutics
CTMX
$346M
$9.56M 0.4%
6,595,801
+792,101
+14% +$1.15M
IMA
53
ImageneBio, Inc. Common Stock
IMA
$150M
$8.89M 0.37%
2,503,071
ALPN
54
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
$8.18M 0.34%
1,135,940
-139,300
-11% -$1M
INFI
55
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$7.56M 0.31%
6,353,645
HLVX icon
56
HilleVax
HLVX
$105M
$6.54M 0.27%
382,452
-61
-0% -$1.04K
ELDN icon
57
Eledon Pharmaceuticals
ELDN
$154M
$6.42M 0.27%
2,326,710
PVLA
58
Palvella Therapeutics, Inc. Common Stock
PVLA
$579M
$5.84M 0.24%
5,080,320
PYXS icon
59
Pyxis Oncology
PYXS
$88.1M
$5.79M 0.24%
2,938,851
CBIO
60
Crescent Biopharma, Inc. Common Stock
CBIO
$181M
$5.27M 0.22%
9,544,262
CDTX icon
61
Cidara Therapeutics
CDTX
$1.6B
$4.31M 0.18%
6,861,127
SPRO icon
62
Spero Therapeutics
SPRO
$117M
$3.86M 0.16%
1,929,376
-1,160,239
-38% -$2.32M
MTEM
63
DELISTED
Molecular Templates, Inc.
MTEM
$3.75M 0.15%
4,996,565
MOLN
64
Molecular Partners
MOLN
$139M
$2.97M 0.12%
443,221
IVA
65
Inventiva
IVA
$780M
$2.66M 0.11%
686,040
ELEV
66
DELISTED
Elevation Oncology
ELEV
$2.61M 0.11%
2,312,200
RNAC icon
67
Cartesian Therapeutics
RNAC
$264M
$2.28M 0.09%
1,391,749
-331,384
-19% -$543K
GBIO icon
68
Generation Bio
GBIO
$40.3M
$1.92M 0.08%
361,824
-1,194,208
-77% -$6.34M
FWP
69
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$1.52M 0.06%
513,791
XFOR icon
70
X4 Pharmaceuticals
XFOR
$71.2M
$1.45M 0.06%
847,879
CALA
71
DELISTED
Calithera Biosciences, Inc
CALA
$1.37M 0.06%
464,742
MEIP icon
72
MEI Pharma
MEIP
$150M
$1.37M 0.06%
3,532,057
CRVS icon
73
Corvus Pharmaceuticals
CRVS
$437M
$1.12M 0.05%
1,370,947
RNTX
74
Rein Therapeutics, Inc. Common Stock
RNTX
$29.7M
$1.09M 0.04%
5,265,555
ELTX icon
75
Elicio Therapeutics
ELTX
$168M
$986K 0.04%
1,071,297